Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
JAAD Case Reports
|
April 5, 2024
Commentary on picosecond Nd:YAG laser therapy for pigmentation due to lichen planus pigmentosus in a patient with skin of color
Carlos G Wambier
Journal of the American Academy of Dermatology
|
August 30, 2020
Reply to: "Comment on 'Androgenetic alopecia present in the majority of patients hospitalized with COVID-19'"
Carlos G Wambier
Ebiomedicine
|
June 16, 2021
Letter to the Editor re: Baldassarri et al., 2021 "Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males"
Soha Ghanian, Carlos G Wambier
The New England Journal of Medicine
|
April 29, 2021
Lucio's Phenomenon
Mahroo Tajalli, Carlos G Wambier
Journal of the American Academy of Dermatology
|
August 17, 2021
Response to "Microneedling with autologous platelet-rich plasma versus microneedling with topical insulin in the treatment of postacne atrophic scars: A simultaneous split-face comparative study"
Soha Ghanian, Carlos G Wambier
Journal of the American Academy of Dermatology
|
February 19, 2025
Most men choose eyebrows versus scalp hair: Response to Mostaghimi et al., "Evaluation of eyebrow and eyelash regrowth and patient satisfaction in the phase 3 THRIVE-AA2 trial of deuruxolitinib in adult patients with alopecia areata"
Austin J Coppinger, Carlos G Wambier
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
October 28, 2017
Air Safety and Personal Protective Equipment for Phenol-Croton Oil Peels
Carlos G Wambier, Flávio L Beltrame
Journal of the American Academy of Dermatology
|
September 24, 2018
Rethinking the classification of alopecia areata
Carlos G Wambier, Brett A King
European Urology
|
March 19, 2022
Re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285-93: Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients
Carlos G Wambier, Gerard J Nau
Frontiers in Medicine
|
August 28, 2020
Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
Flavio A Cadegiani, Carlos G Wambier, Andy Goren
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
JAAD Case Reports
|
April 5, 2024
Commentary on picosecond Nd:YAG laser therapy for pigmentation due to lichen planus pigmentosus in a patient with skin of color
Carlos G Wambier
Journal of the American Academy of Dermatology
|
August 30, 2020
Reply to: "Comment on 'Androgenetic alopecia present in the majority of patients hospitalized with COVID-19'"
Carlos G Wambier
Ebiomedicine
|
June 16, 2021
Letter to the Editor re: Baldassarri et al., 2021 "Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males"
Soha Ghanian, Carlos G Wambier
The New England Journal of Medicine
|
April 29, 2021
Lucio's Phenomenon
Mahroo Tajalli, Carlos G Wambier
Journal of the American Academy of Dermatology
|
August 17, 2021
Response to "Microneedling with autologous platelet-rich plasma versus microneedling with topical insulin in the treatment of postacne atrophic scars: A simultaneous split-face comparative study"
Soha Ghanian, Carlos G Wambier
Journal of the American Academy of Dermatology
|
February 19, 2025
Most men choose eyebrows versus scalp hair: Response to Mostaghimi et al., "Evaluation of eyebrow and eyelash regrowth and patient satisfaction in the phase 3 THRIVE-AA2 trial of deuruxolitinib in adult patients with alopecia areata"
Austin J Coppinger, Carlos G Wambier
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
October 28, 2017
Air Safety and Personal Protective Equipment for Phenol-Croton Oil Peels
Carlos G Wambier, Flávio L Beltrame
Journal of the American Academy of Dermatology
|
September 24, 2018
Rethinking the classification of alopecia areata
Carlos G Wambier, Brett A King
European Urology
|
March 19, 2022
Re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285-93: Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients
Carlos G Wambier, Gerard J Nau
Frontiers in Medicine
|
August 28, 2020
Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
Flavio A Cadegiani, Carlos G Wambier, Andy Goren
Page
of 5